Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
230.9 USD | +0.81% | -0.97% | -2.58% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.58% | 11.76B | |
+1.54% | 42.75B | |
+47.70% | 41.61B | |
+11.75% | 41.34B | |
-8.83% | 26.59B | |
+6.41% | 25.49B | |
-23.28% | 18.12B | |
+29.92% | 12.24B | |
+8.17% | 11B | |
-16.34% | 10.07B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- Morgan Stanley Adjusts Price Target on Charles River Laboratories International to $230 From $241, Maintains Equal-Weight Rating